Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · Real-Time Price · USD
20.65
+0.31 (1.52%)
Dec 20, 2024, 4:00 PM EST - Market closed
Tourmaline Bio Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$54.00
Upside
+161.50%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Dec 11, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $25 | Buy | Reiterates | $25 | +21.07% | Dec 11, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $49 | Strong Buy | Reiterates | $49 | +137.29% | Dec 11, 2024 |
BMO Capital | BMO Capital | Buy Initiates $50 | Buy | Initiates | $50 | +142.13% | Dec 6, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $48 → $49 | Strong Buy | Maintains | $48 → $49 | +137.29% | Nov 11, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $48 | Strong Buy | Reiterates | $48 | +132.45% | Aug 12, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $48 | Strong Buy | Reiterates | $48 | +132.45% | May 14, 2024 |
Truist Securities | Truist Securities | Strong Buy Reiterates $74 | Strong Buy | Reiterates | $74 | +258.35% | Mar 25, 2024 |
Jefferies | Jefferies | Strong Buy Maintains $41 → $72 | Strong Buy | Maintains | $41 → $72 | +248.67% | Mar 20, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $48 | Strong Buy | Reiterates | $48 | +132.45% | Mar 20, 2024 |
Jefferies | Jefferies | Strong Buy Initiates $41 | Strong Buy | Initiates | $41 | +98.55% | Dec 15, 2023 |
Truist Securities | Truist Securities | Strong Buy Initiates $43 | Strong Buy | Initiates | $43 | +108.23% | Nov 17, 2023 |
Guggenheim | Guggenheim | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +142.13% | Oct 31, 2023 |
Piper Sandler | Piper Sandler | Buy Initiates $65 | Buy | Initiates | $65 | +214.77% | Oct 25, 2023 |